Castuner

Endocrine Feedback Loop

Endocrine Society

Endocrine Feedback Loop is a monthly journal club podcast series brought to you by the Endocrine Society. Hosted by endocrinologist Chase Hendrickson, MD, from Vanderbilt University, each episode features an expert educator and a topical specialist dissecting recently published journal articles and discussing implications for clinical practice.

Poddens webbplats

Lyssna i din app

Avsnitt

79 avsnitt

  1. EFL078 - SGLT1 Inhibition for the Treatment of Post-Bariatric Hypoglycemia 35:00
  2. EFL077 - Inflammation vs. Immune-System Dysfunction in PCOS 28:01
  3. EFL076 - Pregnancy Outcomes in PCOS and GDM 46:35
  4. EFL075 - Methimazole Titration and Initial Disease Severity in Graves' Disease 36:54
  5. EFL074 - Taking Levothyroxine Fasting vs. With Breakfast 32:34
  6. EFL073 - Infrequent Zoledronate in Low Fracture Risk 38:07
  7. EFL072 - Pre-Operative Use of Mineralocorticoid-Receptor Antagonists in Primary Aldosteronism 43:48
  8. EFL071 – Taste Changes with Semaglutide 30:54
  9. EFL070 – Dosing Strategies for Remission in Graves Disease 35:12
  10. EFL069 - The Gut Microbiome in Type 1 Diabetes and Obesity 41:00
  11. EFL068 - Hypocalcemia in CKD after Denosumab 35:54
  12. EFL067 - Bariatric Surgery and Changes in Body Composition and Musculoskeletal Health 43:01
  13. EFL066 - Islet Autoantibodies 35:40
  14. EFL065 - MACS and Vertebral Fractures 42:46
  15. EFL064 - Subclinical Thyroid Disease and Cardiovascular Risk Factors 49:17
  16. EFL063 - Diagnosing Adrenal Insufficiency 43:29
  17. EFL062 - Primary Hyperparathyroidism in Pregnancy 48:12
  18. EFL061 - Effectiveness of Lifestyle Intervention in Preventing T2D Based on Genetic Risk 42:51
  19. EFL060 - Topiramate and Metformin for Weight Loss in PCOS 34:30
  20. EFL059 - Testosterone Levels and Fracture Risk in Men 34:12
  21. EFL058 - BMI vs Percent Body Fat in Defining Obesity 43:49
  22. EFL057 - Weaning Glucocorticoids and HPA Recovery 34:14
  23. EFL056 - Renin Measurements in Primary Adrenal Insufficiency 35:20
  24. EFL055 - T3 Replacement in the Treatment of Hypothyroidism 39:18
  25. EFL054 - Renal Protection of Metformin 46:49
  26. EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules 40:58
  27. EFL052 - Osteopenia as a Surgical Indication in Primary Hyperparathyroidism 38:02
  28. EFL051 - PCOS Subtypes Redux 33:28
  29. EFL050 - Bisphosphonates and Atypical Femoral Fractures 46:23
  30. EFL049 - Artificial Intelligence in the Diagnosis of Cushing Syndrome 46:02
  31. EFL048 - Active Surveillance for Larger Malignant Thyroid Nodules 38:21
  32. EFL047 - The Benefits of Tirzepatide in Hispanic/Latino Individuals 39:42
  33. EFL046 - Weight-Loss Surgery in Individuals With Type 2 Diabetes 39:26
  34. EFL045 - Long-Term Effects of Anti-Obesity Medications 51:51
  35. EFL044 - Long-Term Medical Treatment of Graves Disease 46:14
  36. EFL043 - The Impact of Surgical Delay in Thyroid Cancer 37:59
  37. EFL042 - Synergistic Effects of GLP-1 RAs and Exercise 44:35
  38. EFL041 - Improving the Accuracy of the FRAX 44:20
  39. EFL040 - Increased Morbidity With Gynecomastia 43:02
  40. EFL039 - Changes in Pancreas Size and Shape in Type 1 Diabetes 39:39
  41. EFL038 - Aldosterone-to-Renin Ratio Variability in Primary Aldosteronism 38:47
  42. EFL037 - Predicting HPA Function After Pituitary Surgery 45:31
  43. EFL036 - The Glycemic Gap in Hospitalized Patients With COVID 43:25
  44. EFL035 - Cryptorchidism's Impact on Markers of Reproduction 40:58
  45. EFL034 - Hypoparathyroidism Following Thyroidectomy 38:48
  46. EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes 53:28
  47. EFL032 - Inpatient Treatment of Osteoporotic Fractures 51:54
  48. EFL031 - Changes in Glucose Throughout the Menstrual Cycle in T1DM 41:46
  49. EFL030 - Medical Management of Cushing Disease 59:27
  50. EFL029 - Whom to Screen for Cushing Syndrome 43:26